Adverse event, n (%) | Control group (n = 132) | Itopride group (n = 64) | p-value |
At least one adverse event Discontinued due to adverse events Common adverse eventsa Nausea Diarrhea Abdominal pain Vomiting Chest pain Dyspepsia Dyspnea Flatulence Dizziness | 54 (40.9) 37 (26.5) 30 (22.7) 21 (15.9) 6 (4.5) 3 (2.3) 2 (1.5) 2 (1.5) 2 (1.5) 1 (0.8) 1 (0.8) | 14 (21.9) 4 (6.3) 6 (9.4) 4 (6.3) 2 (3.1) 0 (0.0) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) 1 (1.6) | 0.008 <0.001 0.039 0.094 0.931 0.552 0.552 0.552 0.552 0.817 0.817 |